GP1BA
Basic information
Region (hg38): 17:4932277-4935023
Previous symbols: [ "GP1B" ]
Links
Phenotypes
GenCC
Source:
- Bernard-Soulier syndrome (Definitive), mode of inheritance: Semidominant
- Bernard-Soulier syndrome (Supportive), mode of inheritance: AD
- platelet-type von Willebrand disease (Supportive), mode of inheritance: AD
- autosomal dominant macrothrombocytopenia (Supportive), mode of inheritance: AD
- Bernard-Soulier syndrome, type A2, autosomal dominant (Strong), mode of inheritance: AD
- platelet-type von Willebrand disease (Strong), mode of inheritance: AD
- Bernard-Soulier syndrome (Strong), mode of inheritance: AR
- Bernard-Soulier syndrome (Definitive), mode of inheritance: AR
- platelet-type von Willebrand disease (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bernard-Soulier syndrome, type A2; Bernard-Soulier syndrome, type A1; von Willebrand disease, platelet-type | AD/AR | Hematologic; Pharmacogenomic | Preventive measures (eg, in the case of surgery) and treatment of bleeding episodes can be beneficial; Specific medications (eg, certain anesthetics) that interfere with platelet function should be avoided | Hematologic | 18116504; 14081293; 6019024; 6286015; 6798442; 6333901; 2308962; 2052556; 1901273; 1730088; 8384898; 9616133; 11222377; 14711733; 21173099; 22102188; 23014764 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (8 variants)
- Bernard Soulier syndrome (5 variants)
- Bernard-Soulier syndrome, type A2, autosomal dominant (4 variants)
- Pseudo von Willebrand disease (3 variants)
- Bernard-Soulier syndrome, type A1 (2 variants)
- Thrombocytopenia;Abnormal bleeding (1 variants)
- Macrothrombocytopenia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GP1BA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 34 | ||||
missense | 11 | 68 | 93 | |||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 16 | |||||
inframe indel | 9 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 16 | 19 | 74 | 41 | 7 |
Highest pathogenic variant AF is 0.000118
Variants in GP1BA
This is a list of pathogenic ClinVar variants found in the GP1BA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-4932557-A-T | Benign (May 12, 2021) | |||
17-4932600-T-C | not specified | Benign (May 05, 2021) | ||
17-4932636-C-T | Inborn genetic diseases | Uncertain significance (Dec 16, 2022) | ||
17-4932662-T-G | Bernard-Soulier syndrome, type A2, autosomal dominant | Pathogenic (Aug 15, 2023) | ||
17-4932666-A-C | not specified | Uncertain significance (Jun 07, 2024) | ||
17-4932668-G-T | Inborn genetic diseases | Uncertain significance (Feb 16, 2023) | ||
17-4932696-T-A | Bernard-Soulier syndrome, type A2, autosomal dominant • GP1BA-related disorder | Uncertain significance (Jun 13, 2023) | ||
17-4932696-T-C | Pseudo von Willebrand disease;Bernard Soulier syndrome;Bernard-Soulier syndrome, type A2, autosomal dominant | not provided (-) | ||
17-4932701-T-C | Bernard Soulier syndrome | Uncertain significance (-) | ||
17-4932702-G-A | Bernard-Soulier syndrome, type A2, autosomal dominant | Likely pathogenic (-) | ||
17-4932702-G-C | Macrothrombocytopenia | Likely pathogenic (Feb 01, 2019) | ||
17-4932706-CA-C | Bernard Soulier syndrome | Pathogenic (Oct 04, 2020) | ||
17-4932710-A-G | not specified • Bernard-Soulier syndrome, type A2, autosomal dominant;Nonarteritic anterior ischemic optic neuropathy, susceptibility to;Pseudo von Willebrand disease;Bernard Soulier syndrome | Benign/Likely benign (Apr 01, 2023) | ||
17-4932741-C-T | Bernard Soulier syndrome • Bernard-Soulier syndrome, type A2, autosomal dominant • Inborn genetic diseases | Conflicting classifications of pathogenicity (Jan 31, 2024) | ||
17-4932742-G-A | GP1BA-related disorder | Likely benign (Feb 10, 2021) | ||
17-4932751-AAC-A | Macrothrombocytopenia | Pathogenic (Feb 01, 2019) | ||
17-4932764-CTGAG-C | Pathogenic (Mar 03, 2023) | |||
17-4932773-A-G | Bernard-Soulier syndrome, type A2, autosomal dominant • GP1BA-related disorder | Likely pathogenic (Aug 01, 2023) | ||
17-4932775-C-A | Macrothrombocytopenia • not specified • GP1BA-related disorder | Conflicting classifications of pathogenicity (Jul 27, 2023) | ||
17-4932776-C-T | Inborn genetic diseases | Uncertain significance (Apr 05, 2023) | ||
17-4932780-T-C | GP1BA-related disorder | Uncertain significance (Feb 21, 2023) | ||
17-4932795-T-C | Bernard-Soulier syndrome, type A2, autosomal dominant | Uncertain significance (-) | ||
17-4932798-C-T | GP1BA-related disorder | Uncertain significance (Oct 12, 2022) | ||
17-4932804-T-G | Macrothrombocytopenia | Uncertain significance (Feb 01, 2019) | ||
17-4932810-C-T | not specified • Bernard Soulier syndrome • Bernard-Soulier syndrome, type A2, autosomal dominant | Conflicting classifications of pathogenicity (Jul 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GP1BA | protein_coding | protein_coding | ENST00000329125 | 1 | 2734 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00323 | 0.620 | 124505 | 0 | 148 | 124653 | 0.000594 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.303 | 368 | 352 | 1.05 | 0.0000208 | 4149 |
Missense in Polyphen | 68 | 73.815 | 0.92122 | 941 | ||
Synonymous | -0.811 | 178 | 165 | 1.08 | 0.0000105 | 1501 |
Loss of Function | 0.463 | 4 | 5.13 | 0.779 | 2.67e-7 | 55 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000401 | 0.000400 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000503 | 0.000445 |
Finnish | 0.000790 | 0.000789 |
European (Non-Finnish) | 0.00105 | 0.000974 |
Middle Eastern | 0.000503 | 0.000445 |
South Asian | 0.0000997 | 0.0000980 |
Other | 0.000687 | 0.000495 |
dbNSFP
Source:
- Function
- FUNCTION: GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium.;
- Disease
- DISEASE: Non-arteritic anterior ischemic optic neuropathy (NAION) [MIM:258660]: An ocular disease due to ischemic injury to the optic nerve. It usually affects the optic disk and leads to visual loss and optic disk swelling of a pallid nature. Visual loss is usually sudden, or over a few days at most and is usually permanent, with some recovery possibly occurring within the first weeks or months. Patients with small disks having smaller or non- existent cups have an anatomical predisposition for non-arteritic anterior ischemic optic neuropathy. As an ischemic episode evolves, the swelling compromises circulation, with a spiral of ischemia resulting in further neuronal damage. {ECO:0000269|PubMed:14711733}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Bernard-Soulier syndrome (BSS) [MIM:231200]: A coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, thrombocytopenia, and impaired prothrombin consumption. {ECO:0000269|PubMed:10089893, ECO:0000269|PubMed:1730088, ECO:0000269|PubMed:7690774, ECO:0000269|PubMed:7819107, ECO:0000269|PubMed:7873390, ECO:0000269|PubMed:9639514}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bernard-Soulier syndrome A2, autosomal dominant (BSSA2) [MIM:153670]: A coagulation disorder characterized by mild to moderate bleeding tendency, thrombocytopenia, and an increased mean platelet volume. Some individuals have no symptoms. Mild bleeding tendencies manifest as epistaxis, gingival bleeding, menorrhagia, easy bruising, or prolonged bleeding after dental surgery. {ECO:0000269|PubMed:11222377}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pseudo-von Willebrand disease (VWDP) [MIM:177820]: A bleeding disorder characterized by abnormally enhanced binding of von Willebrand factor by the platelet glycoprotein Ib (GP Ib) receptor complex. Hemostatic function is impaired due to the removal of VWF multimers from the circulation. {ECO:0000269|PubMed:14521605, ECO:0000269|PubMed:2052556, ECO:0000269|PubMed:8384898, ECO:0000269|PubMed:8486780}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Platelet activation - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;GP1b-IX-V activation signalling;Platelet Adhesion to exposed collagen;Platelet Aggregation (Plug Formation);Platelet activation, signaling and aggregation;Intrinsic Pathway of Fibrin Clot Formation;Hemostasis;Formation of Fibrin Clot (Clotting Cascade);Transcriptional regulation by RUNX1;Beta2 integrin cell surface interactions
(Consensus)
Recessive Scores
- pRec
- 0.550
Intolerance Scores
- loftool
- 0.630
- rvis_EVS
- 0.14
- rvis_percentile_EVS
- 63.62
Haploinsufficiency Scores
- pHI
- 0.109
- hipred
- N
- hipred_score
- 0.327
- ghis
- 0.412
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.883
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gp1ba
- Phenotype
- hematopoietic system phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- cell morphogenesis;cell adhesion;cell surface receptor signaling pathway;blood coagulation;blood coagulation, intrinsic pathway;platelet activation;regulation of blood coagulation;fibrinolysis;regulation of megakaryocyte differentiation;thrombin-activated receptor signaling pathway;platelet aggregation
- Cellular component
- extracellular space;plasma membrane;integral component of plasma membrane;cell surface;membrane;extracellular matrix;anchored component of external side of plasma membrane;extracellular exosome
- Molecular function
- protein binding;thrombin-activated receptor activity